AU2017278257B2 - Preventing or mitigating chemotherapy induced alopecia using vitamin D - Google Patents

Preventing or mitigating chemotherapy induced alopecia using vitamin D Download PDF

Info

Publication number
AU2017278257B2
AU2017278257B2 AU2017278257A AU2017278257A AU2017278257B2 AU 2017278257 B2 AU2017278257 B2 AU 2017278257B2 AU 2017278257 A AU2017278257 A AU 2017278257A AU 2017278257 A AU2017278257 A AU 2017278257A AU 2017278257 B2 AU2017278257 B2 AU 2017278257B2
Authority
AU
Australia
Prior art keywords
chemotherapy
calcitriol
hydroxyl
subject
vitamin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2017278257A
Other languages
English (en)
Other versions
AU2017278257A1 (en
Inventor
Joaquin J. Jimenez
Niven Rajin Narain
Rangaprasad Sarangarajan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BERG LLC
Original Assignee
BERG LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BERG LLC filed Critical BERG LLC
Publication of AU2017278257A1 publication Critical patent/AU2017278257A1/en
Application granted granted Critical
Publication of AU2017278257B2 publication Critical patent/AU2017278257B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AU2017278257A 2016-06-05 2017-06-05 Preventing or mitigating chemotherapy induced alopecia using vitamin D Active AU2017278257B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662345857P 2016-06-05 2016-06-05
US62/345,857 2016-06-05
PCT/US2017/036011 WO2017214064A1 (en) 2016-06-05 2017-06-05 Preventing or mitigating chemotherapy induced alopecia using vitamin d

Publications (2)

Publication Number Publication Date
AU2017278257A1 AU2017278257A1 (en) 2019-01-24
AU2017278257B2 true AU2017278257B2 (en) 2024-04-18

Family

ID=60578902

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2017278257A Active AU2017278257B2 (en) 2016-06-05 2017-06-05 Preventing or mitigating chemotherapy induced alopecia using vitamin D

Country Status (5)

Country Link
US (2) US20190343847A1 (cg-RX-API-DMAC10.html)
EP (1) EP3463283A4 (cg-RX-API-DMAC10.html)
JP (1) JP7208016B2 (cg-RX-API-DMAC10.html)
AU (1) AU2017278257B2 (cg-RX-API-DMAC10.html)
WO (1) WO2017214064A1 (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX366076B (es) 2009-08-14 2019-06-27 Berg Llc Vitamina d3 y analogos de la misma para tratar alopecia.

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110059917A1 (en) * 2009-08-14 2011-03-10 Joaquin Jimenez Vitamin d3 and analogs thereof for treating alopecia
WO2014194133A1 (en) * 2013-05-29 2014-12-04 Berg Llc Preventing or mitigating chemotherapy induced alopecia using vitamin d

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6844326B2 (en) * 1995-06-07 2005-01-18 Anticancer, Inc. Treatment of alopecia

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110059917A1 (en) * 2009-08-14 2011-03-10 Joaquin Jimenez Vitamin d3 and analogs thereof for treating alopecia
WO2014194133A1 (en) * 2013-05-29 2014-12-04 Berg Llc Preventing or mitigating chemotherapy induced alopecia using vitamin d

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KRAGBALLE et al. British Journal of Dermatology (2009) vol. 161, pages 159-166 *

Also Published As

Publication number Publication date
EP3463283A1 (en) 2019-04-10
CA3026495A1 (en) 2017-12-14
AU2017278257A1 (en) 2019-01-24
JP7208016B2 (ja) 2023-01-18
JP2019525894A (ja) 2019-09-12
WO2017214064A8 (en) 2018-01-11
EP3463283A4 (en) 2020-04-01
WO2017214064A1 (en) 2017-12-14
US20190343847A1 (en) 2019-11-14
US20230302022A1 (en) 2023-09-28

Similar Documents

Publication Publication Date Title
AU2017210660B2 (en) Vitamin D3 and Analogs Thereof for Treating Alopecia
US20220023317A1 (en) Preventing or mitigating chemotherapy induced alopecia using vitamin d
US20230302022A1 (en) Preventing or mitigating chemotherapy induced alopecia using vitamin d
US9125928B2 (en) Agent for suppressing the formation of abnormal skin cells caused by exposure to light
CA3026495C (en) Preventing or mitigating chemotherapy induced alopecia using vitamin d

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)